Role of toll-like receptors in human iris pigment epithelial cells and their response to pathogen-associated molecular patterns

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Mai, Kelly ^a   Chui, Jeanie J Y ^a,b   Di Girolamo, Nick ^a   McCluskey, Peter J ^c   Wakefield, Denis ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Immunology; IPE; PAMPs; TLR; Uveitis

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FLAGELLIN; INTERLEUKIN 8; LIPOPEPTIDE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYINOSINIC POLYCYTIDYLIC ACID; POLYURIDYLIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; IRIS; PIGMENT CELL; PIGMENT EPITHELIUM;

EID: 84904275135     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-20     Document Type: Article

References (35)

1. Toll-like receptors in ocular surface disease. Redfern RL, McDermott AM, Exp Eye Res 2010 90 679 687 10.1016/j.exer.2010.03.012 20346359
2. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P, Br J Ophthalmol 2010 94 271 274 10.1136/bjo.2008.146753 19264730
3. Toll-like receptor 2 expression on human conjunctival epithelial cells: a pathway for Staphylococcus aureus involvement in chronic ocular proinflammatory responses. Cook EB, Stahl JL, Esnault S, Barney NP, Graziano FM, Ann Allergy Asthma Immunol 2005 94 486 497 10.1016/S1081-1206(10)61120-9 15875531 (Pubitemid 40547938)
4. Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF. Kezic J, Taylor S, Gupta S, Planck SR, Rosenzweig HL, Rosenbaum JT, J Leukoc Biol 2011 90 305 311 21610198
5. Intercellular junctions of the iris epithelia in Macaca mulatta. Freddo TF, Invest Ophthalmol Vis Sci 1984 25 1094 1104 6469491 (Pubitemid 14031858)
6. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Semkova I, Kreppel F, Welsandt G, Luther T, Kozlowski J, Janicki H, Kochanek S, Schraermeyer U, Proc Natl Acad Sci U S A 2002 99 13090 13095 10.1073/pnas.202486199 12239351
7. Iris pigment epithelial cells of long evans rats demonstrate phagocytic activity. Rezai KA, Lappas A, Farrokh-siar L, Kohen L, Wiedemann P, Heimann K, Exp Eye Res 1997 65 23 29 10.1006/exer.1997.0307 9237861 (Pubitemid 27322034)
8. The mRNA expression of cytokines and their receptors in cultured iris pigment epithelial cells: a comparison with retinal pigment epithelial cells. Kociok N, Heppekausen H, Schraermeyer U, Esser P, Thumann G, Grisanti S, Heimann K, Exp Eye Res 1998 67 237 250 10.1006/exer.1998.0517 9733590 (Pubitemid 28428272)
9. Development and cellular functions of the iris pigment epithelium. Thumann G, Surv Ophthalmol 2001 45 345 354 10.1016/S0039-6257(00)00195-8 11166346 (Pubitemid 32146436)
10. Toll-like receptors and corneal innate immunity. Kumar A, Yu F-SX, Curr Mol Med 2006 6 327 337 10.2174/156652406776894572 16712478
11. Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Ueta M, Hamuro J, Kiyono H, Kinoshita S, Biochem Biophys Res Commun 2005 331 285 294 10.1016/j.bbrc.2005.02.196 15845391 (Pubitemid 40545174)
12. Expression of toll-like receptors in healthy and allergic conjunctiva. Bonini SMA, Iovieno A, Lambiase A, Bonini S, Ophthalmology 2005 112 1528 1534 16023216
13. Innate immunity in the retina: Toll-like receptor (TLR) signaling in human retinal pigment epithelial cells. Kumar MV, Nagineni CN, Chin MS, Hooks JJ, Detrick B, J Neuroimmunol 2004 153 7 15 10.1016/j.jneuroim.2004.04.018 15265658 (Pubitemid 38950922)
14. Expression of toll-like receptor 4 and its associated lipopolysaccharide receptor complex by resident antigen-presenting cells in the human uvea. Chang JH, McCluskey P, Wakefield D, Invest Ophthalmol Vis Sci 2004 45 1871 1878 10.1167/iovs.03-1113 15161852 (Pubitemid 38868984)
15. The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells. Song PI, Abraham TA, Park Y, Zivony AS, Harten B, Edelhauser HF, Ward SL, Armstrong CA, Ansel JC, Invest Ophthalmol Vis Sci 2001 42 2867 2877 11687531 (Pubitemid 33035285)
16. Lipopolysaccharide-induced expression of intercellular adhesion molecule-1 and chemokines in cultured human corneal fibroblasts. Kumagai N, Fukuda K, Fujitsu Y, Lu Y, Chikamoto N, Nishida T, Investig Ophthalmol Vis Sci 2005 46 114 120 10.1167/iovs.04-0922 (Pubitemid 40041186)
17. Toll-like receptor 4 and CD14 expression in human ciliary body and TLR-4 in human iris endothelial cells. Brito BE, Zamora DO, Bonnah RA, Pan Y, Planck SR, Rosenbaum JT, Exp Eye Res 2004 79 203 208 10.1016/j.exer.2004.03.012 15325567 (Pubitemid 39119409)
18. Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. Kindzelskii AL, Elner VM, Elner SG, Yang D, Hughes BA, Petty HR, J Gen Physiol 2004 124 139 149 10.1085/jgp.200409062 15277575 (Pubitemid 39038188)
19. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Holtkamp GM, Kijlstra A, Peek R, de Vos AF, Prog Retin Eye Res 2001 20 29 48 10.1016/S1350-9462(00)00017-3 11070367
20. Isolation and cultivation of human iris pigment epithelium. Hu DN, Ritch R, McCormick SA, Pelton-Henrion K, Invest Ophthalmol Vis Sci 1992 33 2443 2453 1634342
21. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM, Exp Eye Res 1996 62 155 169 10.1006/exer.1996.0020 8698076 (Pubitemid 26140102)
22. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. Sumbayev VV, Yasinska I, Oniku AE, Streatfield CL, Gibbs BF, PLoS One 2012 7 34259 10.1371/journal.pone.0034259 22470546
23. Iris pigment epithelial cells express a functional lipopolysaccharide receptor complex. Chui JJ, Li MW, Di Girolamo N, Chang JH, McCluskey PJ, Wakefield D, Investig Ophthalmol Vis Sci 2010 51 2558 2567 10.1167/iovs.09-3923
24. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. Erridge C, Kennedy S, Spickett CM, Webb DJ, J Biol Chem 2008 283 24748 24759 10.1074/jbc.M800352200 18559343
25. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H, Eur J Pharmacol 2008 584 40 48 10.1016/j.ejphar.2008.01.026 18299127
26. A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling. Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y, Mol Pharmacol 2006 69 1288 1295 10.1124/mol.105.019695 16373689
27. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S, Eur J Immunol 2004 34 2541 2550 10.1002/eji.200425218 15307186 (Pubitemid 39302811)
28. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M, J Proteome Res 2006 5 862 878 10.1021/pr050420t 16602694
29. Gene expression profile of cultured adult compared to immortalized human RPE. Cai H, Del Priore LV, Mol Vis 2006 12 1 14 16446697 (Pubitemid 43046237)
30. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszynski A, Forsberg LS, Carlson RW, Dixit VM, Science 2013 341 1246 1249 10.1126/science.1240248 23887873
31. The role of cytokines and chemokines in uveitis. Wakefield D, Cuello C, Di Girolamo N, Lloyd A, Dev Ophthalmol 1999 31 53 66 10641199
32. Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Verma MJ, Mukaida N, Vollmer-Conna U, Matushima K, Lloyd A, Wakefield D, Invest Ophthalmol Vis Sci 1999 40 2465 2470 10509638 (Pubitemid 29455471)
33. Investigation of the differential potentials of TLR agonists to elicit uveitis in mice. Allensworth JJ, Planck SR, Rosenbaum JT, Rosenzweig HL, J Leukoc Biol 2011 90 1159 1166 21934069
34. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Fang J, Fang D, Silver PB, Wen F, Li B, Ren X, Lin Q, Caspi RR, Su SB, Investig Ophthalmol Vis Sci 2010 51 3092 3099 10.1167/iovs.09-4754
35. Expression of TLR4-MyD88 and NF-kappaB in the iris during endotoxin-induced uveitis. Li S, Lu H, Hu X, Chen W, Xu Y, Wang J, Mediat Inflamm 2010 2010 748218